🇺🇸 FDA
Patent

US 12208123

Compositions and methods for the treatment of skin conditions

granted A61KA61K31/327A61K35/655

Quick answer

US patent 12208123 (Compositions and methods for the treatment of skin conditions) held by DERMATA THERAPEUTICS, INC. expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DERMATA THERAPEUTICS, INC.
Grant date
Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K31/327, A61K35/655, A61K47/02, A61K9/0014